Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Gatti

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Annals of the New York Academy of Sciences|February 28, 2012
SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic modelsRichard A Gatti
Journal of Molecular Cell Biology|December 25, 2010
MicroRNAs: new players in the DNA damage responseHailiang Hu, Richard A Gatti
Journal of Immunological Methods|December 15, 2010
Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseasesLiutao Du, Richard A Gatti
Current Opinion in Molecular Therapeutics|March 31, 2009
Progress toward therapy with antisense-mediated splicing modulationLiutao Du, Richard A Gatti
Blood|February 27, 2013
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functionsMark Ambrose, Richard A Gatti
European Journal of Neurology|May 23, 2009
A proposed bailout for A-T patients?Richard A Gatti, Susan Perlman
Current Opinion in Allergy and Clinical Immunology|November 4, 2008
New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicalsHailiang Hu, Richard A Gatti
International Journal of Radiation Oncology, Biology, Physics|July 21, 2009
Clinical radiation sensitivity with DNA repair disorders: an overviewJulianne M Pollard, Richard A Gatti
Current Opinion in Allergy and Clinical Immunology|October 28, 2009
DNA double strand break repair defects, primary immunodeficiency disorders, and 'radiosensitivity'Shareef A Nahas, Richard A Gatti
DNA Repair|July 29, 2004
Ataxia-telangiectasia, an evolving phenotypeHelen H Chun, Richard A Gatti
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Annals of the New York Academy of Sciences|February 28, 2012
SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic modelsRichard A Gatti
Journal of Molecular Cell Biology|December 25, 2010
MicroRNAs: new players in the DNA damage responseHailiang Hu, Richard A Gatti
Journal of Immunological Methods|December 15, 2010
Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseasesLiutao Du, Richard A Gatti
Current Opinion in Molecular Therapeutics|March 31, 2009
Progress toward therapy with antisense-mediated splicing modulationLiutao Du, Richard A Gatti
Blood|February 27, 2013
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functionsMark Ambrose, Richard A Gatti
European Journal of Neurology|May 23, 2009
A proposed bailout for A-T patients?Richard A Gatti, Susan Perlman
Current Opinion in Allergy and Clinical Immunology|November 4, 2008
New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicalsHailiang Hu, Richard A Gatti
International Journal of Radiation Oncology, Biology, Physics|July 21, 2009
Clinical radiation sensitivity with DNA repair disorders: an overviewJulianne M Pollard, Richard A Gatti
Current Opinion in Allergy and Clinical Immunology|October 28, 2009
DNA double strand break repair defects, primary immunodeficiency disorders, and 'radiosensitivity'Shareef A Nahas, Richard A Gatti
DNA Repair|July 29, 2004
Ataxia-telangiectasia, an evolving phenotypeHelen H Chun, Richard A Gatti
Pageof 10